Literature DB >> 10542425

The EGFR as a target for viral oncoproteins.

W E Miller1, N Raab-Traub.   

Abstract

The epidermal growth factor receptor (EGFR) is a potent stimulator of the mitogen-activated protein kinase (MAPK) signaling pathway. Chronic stimulation of the EGFR and of multiple steps in the MAPK signaling pathway is involved in the development of cancer. Several tumor viruses encode proteins that induce EGFR expression or stimulate EGFR-mediated signaling and are thus likely to play an important role in the transformation of virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10542425     DOI: 10.1016/s0966-842x(99)01605-4

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  9 in total

1.  Signal transduction networks in cancer: quantitative parameters influence network topology.

Authors:  David J Klinke
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta.

Authors:  Che-Pei Kung; David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

3.  Human tumor virus utilizes exosomes for intercellular communication.

Authors:  David G Meckes; Kathy H Y Shair; Aron R Marquitz; Che-Pei Kung; Rachel H Edwards; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

4.  Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus.

Authors:  M Suomalainen; M Y Nakano; K Boucke; S Keller; U F Greber
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

5.  Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers.

Authors:  H Swaisland; A Laight; L Stafford; H Jones; C Morris; A Dane; R Yates
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

6.  The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex.

Authors:  Vivek Chandra; Manjula Kalia; Krishnan Hajela; Shahid Jameel
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

7.  Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression.

Authors:  Kathleen Kong; Manish Kumar; Midori Taruishi; Ronald T Javier
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

Review 8.  New insights into Epstein‑Barr virus‑associated tumors: Exosomes (Review).

Authors:  Wei Chen; Yao Xie; Tingting Wang; Lin Wang
Journal:  Oncol Rep       Date:  2021-11-15       Impact factor: 3.906

9.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.